About Hautarztpraxis Dres. Leitz
Clinical Trials at Hautarztpraxis Dres. Leitz
During the past decade, Hautarztpraxis Dres. Leitz conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 4 clinical trials were completed, i.e. on
average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 4 clinical trials were completed. i.e. 200%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Hautarztpraxis Dres. Leitz" #1 sponsor was "Eli Lilly and Company" with 2 trials, followed by "Pfizer" with 2 trials
sponsored, "Blueberry Therapeutics" with 1 trials sponsored, "Janssen Research & Development, LLC" with 1 trials sponsored and "Janssen-Cilag G.m.b.H"
with 1 trials sponsored. Other sponsors include -4 different institutions and
companies that sponsored additional 6 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Hautarztpraxis Dres. Leitz"
#1 collaborator was "IQVIA Biotech" with 1 trials as a collaborator and "Incyte Corporation" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at Hautarztpraxis Dres. Leitz
According to Clinical.Site data, the most researched conditions in "Hautarztpraxis Dres. Leitz" are
"Psoriasis" (3 trials), "Dermatitis, Atopic" (2 trials), "Atopic Dermatitis" (1 trials), "Dermatitis" (1 trials) and "Distal Subungual Onychomycosis" (1 trials). Many other conditions were trialed in "Hautarztpraxis Dres. Leitz" in a lesser frequency.
Clinical Trials Intervention Types at Hautarztpraxis Dres. Leitz
Most popular intervention types in "Hautarztpraxis Dres. Leitz" are "Drug" (8 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (4 trials), "Guselkumab" (2 trials), "Abrocitinib 100 mg" (1 trials), "Abrocitinib 200 mg" (1 trials) and "BB2603-1" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Hautarztpraxis Dres. Leitz
The vast majority of trials in "Hautarztpraxis Dres. Leitz" are
8 trials for "All" genders.
Clinical Trials Status at Hautarztpraxis Dres. Leitz
Currently, there are NaN active trials in "Hautarztpraxis Dres. Leitz".
undefined are not yet recruiting,
1 are recruiting,
4 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 3 completed trials in Hautarztpraxis Dres. Leitz,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Hautarztpraxis Dres. Leitz, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 6 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 0 trials that are defined as “Not Applicable".